Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen receptors for cancer immunotherapy

Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen receptors for cancer immunotherapy

US Patent 10759868 · Granted Sep 1, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen receptors for can2024
Universal chimeric antigen receptor T cells specific for CD222023
Methods for engineering highly active T cell for immunotherapy2022
Methods for engineering allogeneic and highly active t cell for immunotherapy2022
CD19 specific chimeric antigen receptor and uses thereof2021
CD19 specific chimeric antigen receptor and uses thereof2021
CD19 specific chimeric antigen receptor and uses thereof2020
Anti-GD3 specific chimeric antigen receptors for cancer immunotherapy2020
ROR1 (NTRKR1) specific chimeric antigen receptors for cancer immunotherapy2020
ROR1 specific multi-chain chimeric antigen receptor2020